Primers sequences (5’- 3’). by Xinyue Bai (13720877)

“…Eight-week-old male wild type (WT) mice and GCN2 knock out (KO) mice were randomly divided into WT control (n = 6), WT exercise(n = 5), GCN2 KO control(n = 5), and GCN2 KO exercise(n = 5) groups. …”

Fig 2 - by Lucas H. Oronel (8525697)

Phosphorylated ERK (ERK-P) is decreased in terminally prion-diseased PrP^CGPIThy-1 L150 mice. by Berta Puig (344828)

“…Note that there is a significant decrease in ERK-P signal (*<i>p</i> = 0.031) in PrP^CGPIThy-1 RML infected mice compared to WTPrP^C mice, whereas no changes are observed for p38-P.…”

<i>Zfp92</i> KO mice have increased blood glucose and decreased <i>Mafb</i> and insulin expression at P1. by Anna B. Osipovich (8742198)

Chestnut extract but not sodium salicylate decreases the severity of diarrhea and enterotoxigenic <i>Escherichia coli</i> F4 shedding in artificially infected piglets by M. Girard (8501361)

“…Feed additives, including bioactive compounds, could be a promising alternative. This study aimed to test two bioactive compounds, sodium salicylate (SA) and a chestnut extract (CE) containing hydrolysable tannins, on the occurrence of PWD. …”

<i>T</i>_<i>2</i> relaxation time measurements in various muscle regions of control (Ctr) and <i>lepb</i>-deficient (<i>lepb</i>^<i>-/-</i>) adult zebrafish. by Muhamed N. Hashem Eeza (15295543)

DataSheet5.pdf by Neha Thakre (4864348)

Supplemental Tables S1-S5 by Kevin Gries (21956942)

DDX5 and DDX17 localize to the nucleus in iSLK.219 and TREx-BCBL1-RTA cells upon lytic reactivation. by Praneet Kaur Sandhu (21156149)

SupplementaryData5.PPT by Elena Silvestri (354706)

“…The administration of the naturally occurring metabolite 3,5-diiodo-L-thyronine (T2) with thyromimetic actions to high fat diet (HFD)-fed rats exerts a systemic hypolipidemic effect, which produces a lack of IMCL accumulation, a shift toward glycolytic fibers and amelioration of insulin sensitivity in gastrocnemius muscle. …”

Comparison of Na⁺ current recordings in control cultures compared with cultures treated with FUdR or AraC prepared from P0-2 rat pups. by Heiko M. Lesslich (12219026)

Data_Sheet_5.XLSX by Behzad Bidadi (4953235)

“…We previously performed a genome-wide association study (GWAS) for neutropenia events in women with breast cancer who were treated with 5-fluorouracil, epirubicin and cyclophosphamide and recruited to the SUCCESS-A trial. …”

Data referring to Fig 5. by Noemi Sgammeglia (16317431)

ART-naive and short-term ART experienced individuals have decreased frequency of CD161-expressing gut homing CD8+ T-cells. by Olivia Briceño (3369029)

Analysis of MD simulations for the SP domain of native PC and its mutant structures (L305R, W342C, G403R, V420E, and W444C) over 200 ns simulations. by Mahvash Farajzadeh-Dehkordi (17468232)

PEGylated pUR4/FUD peptide inhibitor of fibronectin fibrillogenesis decreases fibrosis in murine Unilateral Ureteral Obstruction model of kidney disease by Bianca R. Tomasini-Johansson (5892587)

“…Decreased fibronectin was accompanied by a decrease in collagen and leukocyte infiltration. …”

Image_5_IRE1α-XBP1 Affects the Mitochondrial Function of Aβ25–35-Treated SH-SY5Y Cells by Regulating Mitochondria-Associated Endoplasmic Reticulum Membranes.TIF by Bingcong Chu (10431125)

“…Cells were collected and analyzed by Western blotting, quantitative real-time PCR, electron microscopy, fluorescence microscopy, calcium imaging, and other biochemical assays.</p><p>Results: Aβ-exposed SH-SY5Y cells showed an increased expression of XBP1s and p-IRE1α. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and calcium imaging analysis showed that the IRE1α inhibitor, 4μ8c, reduced Aβ-induced cytotoxicity. …”

Structure and properties of EC5. by Shilpakala Sainath Rao (284155)

“…<p>A. Edmundson helical wheel presentation of 12-mer EC5. …”

S3 Fig - by Mahvash Farajzadeh-Dehkordi (17468232)

Table_5_Effect of high-dose Spirulina supplementation on hospitalized adults with COVID-19: a randomized controlled trial.docx by Mohammad Reza Aghasadeghi (9524778)

“…This study aimed to evaluate the efficacy and safety of high-dose Spirulina platensis for SARS-CoV-2 infection.</p>Study Design<p>We conducted a randomized, controlled, open-label trial involving 189 patients with COVID-19 who were randomly assigned in a 1:1 ratio to an experimental group that received 15.2g of Spirulina supplement plus standard treatment (44 non-intensive care unit (non-ICU) and 47 ICU), or to a control group that received standard treatment alone (46 non-ICU and 52 ICU). …”